Table 1.
Demographic and clinical information
| Parameters | C+ N=10 |
C− N=12 |
HC N=13 |
p |
|---|---|---|---|---|
| Age years | ||||
| Mean (SD) | 74.70 (5.44) | 76.50 (4.28) | 75.54 (6.63) | 0.752 |
| Median (Range) | 72.5 (68-84) | 75.5 (71-86) | 75.00 (67-88) | |
| Race* (N, %) | ||||
| White or Caucasian | 8 (80) | 11 (92) | 13 (100) | 0.373 |
| Black | 1 (10) | 1 (8) | . | |
| Asian, Native Hawaiian | 1 (10) | . | . | |
| Other | . | . | . | |
| Highest grade (N, %) | ||||
| High school or less | 2 (20) | 4 (33) | 4 (31) | 0.805 |
| College or above | 8 (80) | 8 (67) | 9 (69) | |
| AJCC Stage (N, %) | ||||
| DCIS | 1 (10) | 6 (50) | . | |
| Stage I | 1 (10) | 4 (33) | . | |
| Stage II | 8 (80) | 2 (17) | . | |
| Regimen | ||||
| Non-Trastuzumab Regimen (N, %) | 9 (90) | |||
| Trastuzumab Regimen (N, %) | 1 (10) | |||
Abbreviations: TP1: time point 1, TP2: time point 2, C+: Chemotherapy group, C−: No-chemotherapy group, HC: Healthy control group, BMI: Body mass index, SD: Standard deviation, AJCC: American Joint Committee on Cancer, DCIS: Ductal carcinoma in situ and N = number of subjects. For all the above comparisons, ANOVA or Fisher tests were used (for continuous or categorical data, respectively). Parameters were significant with threshold at p of 0.05.